Hierarchical learning of gastric cancer molecular subtypes by integrating multi-modal DNA-level omics data and clinical stratification

Abstract

Molecular subtyping of gastric cancer (GC) aims to comprehend its genetic landscape. However, the efficacy of current subtyping methods is hampered by their mixed use of molecular features, a lack of strategy optimization, and the limited availability of public GC datasets. There is a pressing need for a precise and easily adoptable subtyping approach for early DNA-based screening and treatment. Based on TCGA subtypes, we developed a novel DNA-based hierarchical classifier for gastric cancer molecular subtyping (HCG), which employs gene mutations, copy number aberrations, and methylation patterns as predictors. By incorporating the closely related esophageal adenocarcinomas dataset, we expanded the TCGA GC dataset for the training and testing of HCG (n = 453). The optimization of HCG was achieved through three hierarchical strategies using Lasso-Logistic regression, evaluated by their overall the area under receiver operating characteristic curve (auROC), accuracy, F1 score, the area under precision-recall curve (auPRC) and their capability for clinical stratification using multivariate survival analysis. Subtype-specific DNA alteration biomarkers were discerned through difference tests based on HCG defined subtypes. Our HCG classifier demonstrated superior performance in terms of overall auROC (0.95), accuracy (0.88), F1 score (0.87) and auPRC (0.86), significantly improving the clinical stratification of patients (overall p-value = 0.032). Difference tests identified 25 subtype-specific DNA alterations, including a high mutation rate in the SYNE1, ITGB4, and COL22A1 genes for the MSI subtype, and hypermethylation of ALS2CL, KIAA0406, and RPRD1B genes for the EBV subtype. HCG is an accurate and robust classifier for DNA-based GC molecular subtyping with highly predictive clinical stratification performance. The training and test datasets, along with the analysis programs of HCG, are accessible on the GitHub website (github.com/LabxSCUT).

Keywords

DNA alterations / gastric cancer / hierarchical classification / molecular subtyping / multi-omics

References

[1] Smyth EC , Nilsson M , Grabsch HI , van Grieken NC , Lordick F . Gastric cancer. Lancet. 2020; 396 (10251): 635- 48.

[2] Gao J-P , Xu W , Liu W-T , Yan M , Zhu Z-G . Tumor heterogeneity of gastric cancer: from the perspective of tumor-initiating cell. World J Gastroenterol. 2018; 24: 2567- 81.

[3] Li L , Wang X . Identification of gastric cancer subtypes based on pathway clustering. NPJ Precis Oncol. 2021; 5 (1): 46.

[4] Alsina M , Gullo I , Carneiro F . Intratumoral heterogeneity in gastric cancer: a new challenge to face. Ann Oncol. 2017; 28 (5): 912- 3.

[5] Borrmann R . Geschwülste des magens und duodenums. Verdauungsschlauch: Rachen and Tonsillen; Speiseröhre; Magen and Darm; Bauchfell. Springer Vienna. 1926: 812- 1054.

[6] Lauren P . The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965; 64 (1): 31- 49.

[7] Garattini SK , Basile D , Cattaneo M , Fanotto V , Ongaro E , Bonotto M , et al. Molecular classifications of gastric cancers: novel insights and possible future applications. World J Gastrointest Oncol. 2017; 9 (5): 194- 208.

[8] Serra O , Galán M , Ginesta MM , Calvo M , Sala N , Salazar R . Comparison and applicability of molecular classifications for gastric cancer. Cancer Treat Rev. 2019; 77: 29- 34.

[9] Wang Q , Liu G , Hu C . Molecular classification of gastric adenocarcinoma. Gastroenterology Res. 2019; 12 (6): 275- 82.

[10] Lei Z , Tan IB , Das K , Deng N , Zouridis H , Pattison S , et al. Identification of molecular subtypes of gastric cancer with different responses to pi3-kinase inhibitors and 5-fluorouracil. Gastroenterology. 2013; 145 (3): 554- 65.

[11] Network CGAR . Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014; 513 (7517): 202- 9.

[12] Katona BW , Rustgi AK . Gastric cancer genomics: advances and future directions. Cell Mol Gastroenter. 2017; 3 (2): 211- 7.

[13] Sohn BH , Hwang J-E , Jang H-J , Lee H-S , Oh SC , Shim J-J , et al. Clinical significance of four molecular subtypes of gastric cancer identified by the cancer genome atlas project. Clin Cancer Res. 2017; 23 (15): 4441- 9.

[14] Nshizirungu JP , Bennis S , Mellouki I , Sekal M , Benajah D-A , Lahmidani N , et al. Reproduction of the cancer genome atlas (TCGA) and Asian cancer research group (ACRG) gastric cancer molecular classifications and their association with clinicopathological characteristics and overall survival in Moroccan patients. Dis Markers. 2021; 2021: 1- 12.

[15] Wörheide MA , Krumsiek J , Kastenmüller G , Arnold M . Multi-omics integration in biomedical research—a metabolomics-centric review. Anal Chim Acta. 2021; 1141: 144- 62.

[16] Pinu FR , Beale DJ , Paten AM , Kouremenos K , Swarup S , Schirra HJ , et al. Systems biology and multi-omics integration: viewpoints from the metabolomics research community. Metabolites. 2019; 9 (4): 76.

[17] Voillet V , Besse P , Liaubet L , San Cristobal M , González I . Handling missing rows in multi-omics data integration: multiple imputation in multiple factor analysis framework. BMC Bioinf. 2016; 17: 1- 16.

[18] Röcken C . Molecular classification of gastric cancer. Expert Rev Mol Diagn. 2017; 17 (3): 293- 301.

[19] Liu C , Duan Y , Zhou Q , Wang Y , Gao Y , Kan H , et al. A classification method of gastric cancer subtype based on residual graph convolution network. Front Genet. 2022; 13.

[20] Raser JM , O'shea EK . Noise in gene expression: origins, consequences, and control. Science. 2005; 309 (5743): 2010- 3.

[21] Zhou Q , Yuan Y , Lu H , Li X , Liu Z , Gan J , et al. Cancer functional states-based molecular subtypes of gastric cancer. J Transl Med. 2023; 21 (1): 80.

[22] Tahara T , Tahara S , Horiguchi N , Okubo M , Terada T , Yamada H , et al. Molecular subtyping of gastric cancer combining genetic and epigenetic anomalies provides distinct clinicopathological features and prognostic impacts. Hum Mutat. 2019; 40 (3): 347- 54.

[23] Lian Q , Wang B , Fan L , Sun J , Wang G , Zhang J . DNA methylation data-based molecular subtype classification and prediction in patients with gastric cancer. Cancer Cell Int. 2020; 20 (1): 349.

[24] Cristescu R , Lee J , Nebozhyn M , Kim K-M , Ting JC , Wong SS , et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med. 2015; 21 (5): 449- 56.

[25] Sanchez-Vega F , Mina M , Armenia J , Chatila WK , Luna A , La KC , et al. Oncogenic signaling pathways in the cancer genome atlas. Cell. 2018; 173 (2): 321- 37.

[26] Coleman HG , Xie S-H , Lagergren J . The epidemiology of esophageal adenocarcinoma. Gastroenterology. 2018; 154 (2): 390- 405.

[27] Crick F . Central dogma of molecular biology. Nature. 1970; 227 (5258): 561- 3.

[28] Watson JD , Crick FH . Molecular structure of nucleic acids: a structure for deoxyribose nucleic acid. Nature. 1953; 171 (4356): 737- 8.

[29] Franklin RE , Gosling RG . Evidence for 2-chain helix in crystalline structure of sodium deoxyribonucleate. Nature. 1953; 172 (4369): 156- 7.

[30] Breslauer KJ , Frank R , Blöcker H , Marky LA . Predicting DNA duplex stability from the base sequence. Proc Natl Acad Sci USA. 1986; 83 (11): 3746- 50.

[31] Kool ET , Morales JC , Guckian KM . Mimicking the structure and function of DNA: insights into DNA stability and replication. Angew Chem Int Ed. 2000; 39 (6): 990- 1009.

[32] Li X , Wu WKK , Xing R , Wong SH , Liu Y , Fang X , et al. Distinct subtypes of gastric cancer defined by molecular characterization include novel mutational signatures with prognostic capability. Cancer Res. 2016; 76 (7): 1724- 32.

[33] Usui G , Matsusaka K , Mano Y , Urabe M , Funata S , Fukayama M , et al. DNA methylation and genetic aberrations in gastric cancer. Digestion. 2021; 102 (1): 25- 32.

[34] Zhao L , Lee VH , Ng MK , Yan H , Bijlsma MF . Molecular subtyping of cancer: current status and moving toward clinical applications. Briefings Bioinf. 2019; 20 (2): 572- 84.

[35] Hayakawa Y , Sethi N , Sepulveda AR , Bass AJ , Wang TC . Oesophageal adenocarcinoma and gastric cancer: should we mind the gap? Nat Rev Cancer. 2016; 16 (5): 305- 18.

[36] Salem ME , Puccini A , Xiu J , Raghavan D , Lenz HJ , Korn WM , et al. Comparative molecular analyses of esophageal squamous cell carcinoma, esophageal adenocarcinoma, and gastric adenocarcinoma. Oncol. 2018; 23 (11): 1319- 27.

[37] Shankaran V , Xiao H , Bertwistle D , Zhang Y , You M , Abraham P , et al. A comparison of real-world treatment patterns and clinical outcomes in patients receiving first-line therapy for unresectable advanced gastric or gastroesophageal junction cancer versus esophageal adenocarcinomas. Adv Ther. 2021; 38 (1): 707- 20.

[38] Chawla NV , Bowyer KW , Hall LO , Kegelmeyer WP . Smote: synthetic minority over-sampling technique. J Artif Intell Res. 2002; 16: 321- 57.

[39] Ratti M , Lampis A , Hahne JC , Passalacqua R , Valeri N . Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approaches. Cell Mol Life Sci. 2018; 75 (22): 4151- 62.

[40] Wang K , Yuen ST , Xu J , Lee SP , Yan HH , Shi ST , et al. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat Genet. 2014; 46 (6): 573- 82.

[41] Rajagopalan H , Nowak MA , Vogelstein B , Lengauer C . The significance of unstable chromosomes in colorectal cancer. Nat Rev Cancer. 2003; 3 (9): 695- 701.

[42] Geigl JB , Obenauf AC , Schwarzbraun T , Speicher MR . Defining ‘chromosomal instability’. Trends Genet. 2008; 24 (2): 64- 9.

[43] Ling Y , Watanabe Y , Nagahashi M , Shimada Y , Ichikawa H , Wakai T , et al. Genetic profiling for diffuse type and genomically stable subtypes in gastric cancer. Comput Struct Biotechnol J. 2020; 18: 3301- 8.

[44] Jácome AAdA , Lima EMd , Kazzi AI , Chaves GF , Mendonça DCd , Maciel MM , et al. Epstein-Barr virus-positive gastric cancer: a distinct molecular subtype of the disease? Rev Soc Bras Med Trop. 2016; 49 (2): 150- 7.

[45] Luo W , Fedda F , Lynch P , Tan D . Cdh1 gene and hereditary diffuse gastric cancer syndrome: molecular and histological alterations and implications for diagnosis and treatment. Front Pharmacol. 2018; 9: 1421.

[46] Imai K , Hirata S , Irie A , Senju S , Ikuta Y , Yokomine K , et al. Identification of a novel tumor-associated antigen, cadherin 3/p-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers. Clin Cancer Res. 2008; 14 (20): 6487- 95.

[47] Zhang H , Ma R , Wang X , Su Z , Chen X , Shi D , et al. Kif26b, a novel oncogene, promotes proliferation and metastasis by activating the vegf pathway in gastric cancer. Oncogene. 2017; 36 (40): 5609- 19.

[48] Qi M , Jiao M , Li X , Hu J , Wang L , Zou Y , et al. Cul4b promotes gastric cancer invasion and metastasis-involvement of upregulation of her2. Oncogene. 2018; 37 (8): 1075- 85.

[49] O'Donovan KJ , Diedler J , Couture GC , Fak JJ , Darnell RB . The onconeural antigen cdr2 is a novel apc/c target that acts in mitosis to regulate c-myc target genes in mammalian tumor cells. PLoS One. 2010; 5 (4): e10045.

[50] Li Y , Liu Z , Zhang Y . Expression and prognostic impact of fzds in pancreatic adenocarcinoma. BMC Gastroenterol. 2021; 21 (1): 79.

[51] Di Bartolomeo M , Morano F , Raimondi A , Miceli R , Corallo S , Tamborini E , et al. Prognostic and predictive value of microsatellite instability, inflammatory reaction and pd-l1 in gastric cancer patients treated with either adjuvant 5-fu/lv or sequential folfiri followed by cisplatin and docetaxel: a translational analysis from the itaca-s trial. Oncol. 2020; 25 (3): e460- 8.

[52] Hinata M , Ushiku T . Detecting immunotherapy-sensitive subtype in gastric cancer using histologic image-based deep learning. Sci Rep. 2021; 11 (1): 22636.

[53] Nusse R , Clevers H . Wnt/β-catenin signaling, disease, and emerging therapeutic modalities. Cell. 2017; 169 (6): 985- 99.

[54] Nakano A , Pulkkinen L , Murrell D , Rico J , Lucky AW , Garzon M , et al. Epidermolysis bullosa with congenital pyloric atresia: novel mutations in the β4 integrin gene (itgb4) and genotype/phenotype correlations. Pediatr Res. 2001; 49 (5): 618- 26.

[55] Rima M , Daghsni M , Lopez A , Fajloun Z , Lefrancois L , Dunach M , et al. Down-regulation of the wnt/β-catenin signaling pathway by cacnb4. Mol Biol Cell. 2017; 28 (25): 3699- 708.

[56] Wang J , Li R , He Y , Yi Y , Wu H , Liang Z . Next-generation sequencing reveals heterogeneous genetic alterations in key signaling pathways of mismatch repair deficient colorectal carcinomas. Mod Pathol. 2020; 33 (12): 2591- 601.

[57] Chen Z-H , Yan S-M , Chen X-X , Zhang Q , Liu S-X , Liu Y , et al. The genomic architecture of ebv and infected gastric tissue from precursor lesions to carcinoma. Genome Med. 2021; 13: 1- 22.

[58] Jia Y , Yan Q , Zheng Y , Li L , Zhang B , Chang Z , et al. Long non-coding rna neat1 mediated rprd1b stability facilitates fatty acid metabolism and lymph node metastasis via c-jun/c-fos/srebp1 axis in gastric cancer. J Exp Clin Cancer Res. 2022; 41: 1- 20.

[59] Hurov KE , Cotta-Ramusino C , Elledge SJ . A genetic screen identifies the triple t complex required for DNA damage signaling and atm and atr stability. Gene Dev. 2010; 24 (17): 1939- 50.

[60] Higgins MJ , Baselga J . Targeted therapies for breast cancer. J Clin Investig. 2011; 121 (10): 3797- 803.

[61] Roepman P , Schlicker A , Tabernero J , Majewski I , Tian S , Moreno V , et al. Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition. Int J Cancer. 2014; 134 (3): 552- 62.

[62] Li T , Kung H-J , Mack PC , Gandara DR . Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies. J Clin Oncol. 2013; 31 (8): 1039- 49.

[63] Ahn S , Lee S-J , Kim Y , Kim A , Shin N , Choi KU , et al. High-throughput protein and mrna expression-based classification of gastric cancers can identify clinically distinct subtypes, concordant with recent molecular classifications. Am J Surg Pathol. 2017; 41 (1): 106- 15.

[64] Bonev B , Cavalli G . Organization and function of the 3D genome. Nat Rev Genet. 2016; 17 (11): 661- 78.

[65] Buitrago D , Labrador M , Arcon JP , Lema R , Flores O , Esteve-Codina A , et al. Impact of DNA methylation on 3D genome structure. Nat Commun. 2021; 12 (1): 3243.

[66] Pretzsch E , Bösch F , Todorova R , Nieß H , Jacob S , Guba M , et al. Molecular subtyping of gastric cancer according to acrg using immunohistochemistry-correlation with clinical parameters. Pathol Res Pract. 2022; 231: 153797.

[67] Ramos MFKP , Pereira MA , de Mello ES , dos Santos Cirqueira C , Zilberstein B , Alves VAF , et al. Gastric cancer molecular classification based on immunohistochemistry and in situ hybridization: analysis in western patients after curative-intent surgery. World J Clin Oncol. 2021; 12 (8): 688- 701.

[68] Khushman Md , Patel GK , Maharjan AS , McMillin GA , Nelson C , Hosein P , et al. The prevalence and clinical relevance of 2r/2r tyms genotype in patients with gastrointestinal malignancies treated with fluoropyrimidine-based chemotherapy regimens. Pharmacogenomics J. 2021; 21 (3): 308- 17.

[69] Chao J , Fuchs CS , Shitara K , Tabernero J , Muro K , Van Cutsem E , et al. Assessment of pembrolizumab therapy for the treatment of microsatellite instability-high gastric or gastroesophageal junction cancer among patients in the keynote-059, keynote-061, and keynote-062 clinical trials. JAMA Oncol. 2021; 7 (6): 895- 902.

[70] Kim SY , Choi YY , An JY , Shin HB , Jo A , Choi H , et al. The benefit of microsatellite instability is attenuated by chemotherapy in stage ii and stage iii gastric cancer: results from a large cohort with subgroup analyses. Int J Cancer. 2015; 137 (4): 819- 25.

[71] Cai Z , Rui W , Li S , Fingerhut A , Sun J , Ma J , et al. Microsatellite status affects tumor response and survival in patients undergoing neoadjuvant chemotherapy for clinical stage iii gastric cancer. Front Oncol. 2020; 10: 614785.

[72] Chen S , Gan M , Lv H , Jiang R . Deepcape: a deep convolutional neural network for the accurate prediction of enhancers. Dev Reprod Biol. 2021; 19: 565- 77.

[73] Chen S , Liu Q , Cui X , Feng Z , Li C , Wang X , et al. Openannotate: a web server to annotate the chromatin accessibility of genomic regions. Nucleic Acids Res. 2021; 49: W483- 90.

[74] Cerami E , Gao J , Dogrusoz U , Gross BE , Sumer SO , Aksoy BA , et al. The CBIO cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012; 2: 401- 4.

[75] Fleischer T , Frigessi A , Johnson KC , Edvardsen H , Touleimat N , Klajic J , et al. Genome-wide DNA methylation profiles in progression to in situand invasive carcinoma of the breast with impact on gene transcription and prognosis. Genome Biol. 2014; 15: 1- 13.

[76] Suh Y-S , Na D , Lee J-S , Chae J , Kim E , Jang G , et al. Comprehensive molecular characterization of adenocarcinoma of the gastroesophageal junction between esophageal and gastric adenocarcinomas. Ann Surg. 2022; 275: 706- 17.

[77] Yang X , Gao L , Zhang S . Comparative pan-cancer DNA methylation analysis reveals cancer common and specific patterns. Briefings Bioinf. 2017; 18: 761- 73.

RIGHTS & PERMISSIONS

2024 2024 The Authors. Quantitative Biology published by John Wiley & Sons Australia, Ltd on behalf of Higher Education Press.